What did the WHI re-analyses change?

Age-stratified analyses showed that starting within ~10 years of menopause and under 60 has a more favorable risk-benefit profile than the 2002 headlines implied.

Is HRT safe to start at my age?

For most healthy symptomatic women under 60 or within 10 years of menopause, benefits outweigh risks. It's individual — decide with a clinician.

Does HRT prevent dementia or heart disease?

It reduces fractures and treats symptoms, but is not recommended solely for disease prevention, and trials show no cognitive benefit.

Body · Letter

The HRT story after 2024 — what the re-analyses actually changed.

Creator: After Forty Feel Editorial
Published: 2026-03-15

The 2002 WHI paper took hormone therapy out of mainstream medicine almost overnight. The re-analyses since have reframed it — not into a miracle, but into a reasonable, individualized symptom treatment for the right women at the right time.

After Forty Feel EditorialMedically reviewed by [reviewer, credentials] · Updated June 2026

Editorial: Reader-funded and independent. Not medical advice. We take no money from supplement brands to shape coverage. Editorial standards.

What the WHI undersold

The 2002 WHI reported higher risks on combined estrogen-plus-progestin, and the headlines did the rest. What got lost: the average participant was ~63, on a formulation that isn't standard today. The cardiovascular signal was concentrated in that older cohort, not in 50-year-olds starting near menopause.

What the re-analyses showed

Stratified by age, the picture changed. For women starting within 10 years of their final period, the cardiovascular profile is more favorable, and the breast-cancer absolute risk increase is smaller and proportional to baseline risk. Major societies (The Menopause Society, Endocrine Society, British Menopause Society) hold that hormone therapy in early postmenopause is appropriate symptom management for most healthy women under 60.

One honest boundary

HRT is the most effective treatment for hot flashes, night sweats, and genitourinary symptoms, and it reduces fracture risk. But it is not recommended purely to prevent heart disease or dementia, and the best trials (KEEPS, ELITE) found no cognitive benefit (cognition explainer). Frame the conversation around symptom relief, not disease prevention.

Questions to bring your clinician

What's my personal baseline risk for breast cancer, CVD, and fracture?
Transdermal vs oral estradiol — which fits me, and why?
Micronized progesterone vs synthetic progestin?
What's the plan to reassess at 1, 3, and 5 years?

One thoughtful letter every Sunday

Research-led, reader-funded, no supplement-brand sponsorships. Plus the free guides we publish.

Sources: WHI Writing Group, JAMA 2002 (PubMed); Manson et al. re-analysis, NEJM 2013 (PubMed); The Menopause Society 2022 Hormone Therapy Position Statement.